Evaluation of antibody response to BNT162b2 mRNA COVID-19 vaccine in patients affected by immune-mediated inflammatory diseases up to 5 months after vaccination
评估免疫介导性炎症疾病患者接种 BNT162b2 mRNA COVID-19 疫苗后长达 5 个月的抗体反应
期刊:Clinical and Experimental Medicine
影响因子:3.5
doi:10.1007/s10238-021-00771-3
Firinu, Davide; Perra, Andrea; Campagna, Marcello; Littera, Roberto; Fenu, Giuseppe; Meloni, Federico; Cipri, Selene; Sedda, Francesca; Conti, Maria; Miglianti, Michela; Costanzo, Giulia; Secci, Marta; Usai, Gianmario; Carta, Mauro Giovanni; Cappai, Riccardo; Orrù, Germano; Del Giacco, Stefano; Coghe, Ferdinando; Chessa, Luchino